249 related articles for article (PubMed ID: 33148791)
1. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation.
Farooq M; Herman JG
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2416-2422. PubMed ID: 33148791
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Lung Cancer Screening and Detection.
Ostrin EJ; Sidransky D; Spira A; Hanash SM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2411-2415. PubMed ID: 33093160
[TBL] [Abstract][Full Text] [Related]
3. Methylation in Lung Cancer: A Brief Review.
Gu C; Chen C
Methods Mol Biol; 2020; 2204():91-97. PubMed ID: 32710317
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
5. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
Boeri M; Sestini S; Fortunato O; Verri C; Suatoni P; Pastorino U; Sozzi G
Expert Rev Mol Diagn; 2015 Jun; 15(6):801-13. PubMed ID: 25924864
[TBL] [Abstract][Full Text] [Related]
6. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA.
Ren AH; Fiala CA; Diamandis EP; Kulasingam V
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2568-2574. PubMed ID: 32277003
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers and Strategies for Early Detection of Ovarian Cancer.
Bast RC; Lu Z; Han CY; Lu KH; Anderson KS; Drescher CW; Skates SJ
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2504-2512. PubMed ID: 33051337
[TBL] [Abstract][Full Text] [Related]
9. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
10. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
11. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.
Anglim PP; Alonzo TA; Laird-Offringa IA
Mol Cancer; 2008 Oct; 7():81. PubMed ID: 18947422
[TBL] [Abstract][Full Text] [Related]
13. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
14. Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia.
Cohen JD; Diergaarde B; Papadopoulos N; Kinzler KW; Schoen RE
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2441-2453. PubMed ID: 33033144
[TBL] [Abstract][Full Text] [Related]
15. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
16. Molecular sputum analysis for the diagnosis of lung cancer.
Hubers AJ; Prinsen CF; Sozzi G; Witte BI; Thunnissen E
Br J Cancer; 2013 Aug; 109(3):530-7. PubMed ID: 23868001
[TBL] [Abstract][Full Text] [Related]
17. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer.
Wei B; Wu F; Xing W; Sun H; Yan C; Zhao C; Wang D; Chen X; Chen Y; Li M; Ma J
Sci Rep; 2021 Aug; 11(1):16782. PubMed ID: 34408226
[TBL] [Abstract][Full Text] [Related]
18. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
19. Multiplex Digital Methylation-Specific PCR for Noninvasive Screening of Lung Cancer.
Zhao Y; O'Keefe CM; Hsieh K; Cope L; Joyce SC; Pisanic TR; Herman JG; Wang TH
Adv Sci (Weinh); 2023 Jun; 10(16):e2206518. PubMed ID: 37039321
[TBL] [Abstract][Full Text] [Related]
20. Serum and blood based biomarkers for lung cancer screening: a systematic review.
Chu GCW; Lazare K; Sullivan F
BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
